A citation-based method for searching scientific literature

Irene Maeve Rea, David S Gibson, Victoria McGilligan, Susan E McNerlan, H Denis Alexander, Owen A Ross. Front Immunol 2018
Times Cited: 282







List of co-cited articles
529 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Synaptic plasticity: multiple forms, functions, and mechanisms.
Ami Citri, Robert C Malenka. Neuropsychopharmacology 2008
727
1

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.
Amy M Pooler, Manuela Polydoro, Eduardo A Maury, Samantha B Nicholls, Snigdha M Reddy, Susanne Wegmann, Christopher William, Lubna Saqran, Ozge Cagsal-Getkin, Rose Pitstick,[...]. Acta Neuropathol Commun 2015
113
1

Association of epileptiform abnormalities and seizures in Alzheimer disease.
Alice D Lam, Rani A Sarkis, Kyle R Pellerin, Jin Jing, Barbara A Dworetzky, Daniel B Hoch, Claire S Jacobs, Jong Woo Lee, Daniel S Weisholtz, Rodrigo Zepeda,[...]. Neurology 2020
13
7

Synapse loss and progress of Alzheimer's disease -A network model.
G Kashyap, D Bapat, D Das, R Gowaikar, R E Amritkar, G Rangarajan, V Ravindranath, G Ambika. Sci Rep 2019
29
3

Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies.
Yu Gao, Lin Tan, Jin-Tai Yu, Lan Tan. Curr Alzheimer Res 2018
56
1

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.
R D Terry, E Masliah, D P Salmon, N Butters, R DeTeresa, R Hill, L A Hansen, R Katzman. Ann Neurol 1991
1

Roles of sigma-1 receptors in Alzheimer's disease.
Jia-Li Jin, Min Fang, Yan-Xin Zhao, Xue-Yuan Liu. Int J Clin Exp Med 2015
22
4

Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain.
Lei Zhao, Zhongqi Li, Joaquim S L Vong, Xinyi Chen, Hei-Ming Lai, Leo Y C Yan, Junzhe Huang, Samuel K H Sy, Xiaoyu Tian, Yu Huang,[...]. Nat Commun 2020
8
12

GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment.
Yilan Xu, Manna Zhao, Yuying Han, Heng Zhang. Front Neurosci 2020
17
5

Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.
C Frank Bennett, Adrian R Krainer, Don W Cleveland. Annu Rev Neurosci 2019
61
1

Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
Panos Theofilas, Alexander J Ehrenberg, Sara Dunlop, Ana T Di Lorenzo Alho, Austin Nguy, Renata Elaine Paraizo Leite, Roberta Diehl Rodriguez, Maria B Mejia, Claudia K Suemoto, Renata Eloah De Lucena Ferretti-Rebustini,[...]. Alzheimers Dement 2017
121
1

GABA receptor mechanisms in the central nervous system.
L Sivilotti, A Nistri. Prog Neurobiol 1991
455
1

Emerging pathways driving early synaptic pathology in Alzheimer's disease.
Clark A Briggs, Shreaya Chakroborty, Grace E Stutzmann. Biochem Biophys Res Commun 2017
49
2

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.
Seung Pil Yun, Tae-In Kam, Nikhil Panicker, SangMin Kim, Yumin Oh, Jong-Sung Park, Seung-Hwan Kwon, Yong Joo Park, Senthilkumar S Karuppagounder, Hyejin Park,[...]. Nat Med 2018
310
1

LTP requires a reserve pool of glutamate receptors independent of subunit type.
Adam J Granger, Yun Shi, Wei Lu, Manuel Cerpas, Roger A Nicoll. Nature 2013
200
1

Alzheimer's disease: Targeting the Cholinergic System.
Talita H Ferreira-Vieira, Isabella M Guimaraes, Flavia R Silva, Fabiola M Ribeiro. Curr Neuropharmacol 2016
372
1

Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.
Karan Govindpani, Beatriz Calvo-Flores Guzmán, Chitra Vinnakota, Henry J Waldvogel, Richard L Faull, Andrea Kwakowsky. Int J Mol Sci 2017
79
1

Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
Jian-ping Jia, Jian-min Jia, Wei-dong Zhou, Min Xu, Chang-biao Chu, Xin Yan, Yong-xin Sun. Chin Med J (Engl) 2004
25
4

A novel APP mutation (D678H) in a Taiwanese patient exhibiting dementia and cerebral microvasculopathy.
Min-Yu Lan, Jia-Shou Liu, Yi-Shan Wu, Chen-Huei Peng, Yung-Yee Chang. J Clin Neurosci 2014
22
4

Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Mostafa Bentahir, Omar Nyabi, Jan Verhamme, Alexandra Tolia, Katrien Horré, Jens Wiltfang, Hermann Esselmann, Bart De Strooper. J Neurochem 2006
300
1

Orexin and Alzheimer's Disease.
Claudio Liguori. Curr Top Behav Neurosci 2017
27
3


Glycogen synthase kinase-3 signaling in Alzheimer's disease.
Elisabetta Lauretti, Ozlem Dincer, Domenico Praticò. Biochim Biophys Acta Mol Cell Res 2020
40
2

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.
Robert A Mitchell, Nathan Herrmann, Krista L Lanctôt. CNS Neurosci Ther 2011
57
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.